Medplus Health Services Ltd

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 September 2026, providing investors with the latest insights into its performance and outlook.

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with the latest insights into the company’s performance and outlook.

For the fifth consecutive session, Medplus Health Services closed lower, slipping to a fresh 52-week low of Rs 647.25 on 20 Aug 2026, marking a significant 36.5% decline from its 52-week high of Rs 1020.35. This persistent downtrend contrasts sharply with the broader market, where the Sensex gained 0.71% and hovered near recent highs.

For the fifth consecutive session, Medplus Health Services Ltd closed lower, breaching its 52-week low at Rs 650 on 19 Aug 2026, marking a 21.7% decline over the past year and underperforming the Sensex by a wide margin.

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Medplus Health Services Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined to ₹704.95, down 1.34% from the previous close of ₹714.55, reflecting growing investor caution amid deteriorating technical signals and a recent downgrade in its Mojo Grade from Hold to Sell.

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Medplus Health Services Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price action.

For the second consecutive session, Medplus Health Services Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 653.8 on 22 Jul 2026. This drop comes amid heightened volatility and a broader market pullback, with the stock underperforming its sector by over 16% today alone.

MedPlus Health Services Ltd., one of India's leading pharmacy retail chains, reported a sharp decline in profitability for Q1 FY27, with consolidated net profit plummeting 48.14% quarter-on-quarter to ₹33.18 crores from ₹63.98 crores in Q4 FY26. The disappointing results triggered a severe market reaction, with the stock crashing 15.16% to ₹674.85, bringing it perilously close to its 52-week low of ₹653.80. The ₹8,107-crore market capitalisation company's troubles stem from deteriorating operating margins and mounting operational challenges despite maintaining revenue momentum.

Medplus Health Services Ltd witnessed a significant gap down at the opening of trade on 22 Jul 2026, reflecting heightened market concerns. The stock opened nearly 10% lower, extending a recent downward trend amid a challenging trading environment for the retailing sector.

Medplus Health Services Ltd experienced significant intraday weakness on 22 Jul 2026, hitting a new 52-week low of Rs 655.4 as the stock faced intense selling pressure. The decline of 16.03% on the day marked a sharp underperformance relative to its sector and the broader market, reflecting immediate pressures and subdued market sentiment.

Medplus Health Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price declines and sector headwinds.

Medplus Health Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial trends despite ongoing challenges in management efficiency and stock performance relative to benchmarks.

Medplus Health Services Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and persistent bearish undertones in the retailing sector.

Medplus Health Services Ltd, a small-cap player in the retailing sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, Bollinger Bands, and moving averages, suggest a cautious outlook for investors as the stock navigates a challenging market environment.